<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Viridian Therapeutics, Inc.DE (VRDN) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/vrdn/filings</link>
    <description>Latest company filings for Viridian Therapeutics, Inc.DE (VRDN) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Thu, 09 Jul 2026 21:49:57 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/vrdn/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526239246/d111034d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-239246</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2026-05-26.]]></description>
      <pubDate>Tue, 26 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000110465926062332/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-062332</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000110465926060294/xslF345X06/tm2614357-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-060294</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000110465926060292/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-060292</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526216709/d154062d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-216709</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526214614/d125234d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-214614</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Prospectus supplement (424B5) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526214607/d109155d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-214607</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Prospectus supplement (424B5) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000117266126001638/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001172661-26-001638</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Free writing prospectus (FWP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526210127/d152255dfwp.htm</link>
      <guid isPermaLink="false">0001193125-26-210127</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Free writing prospectus (FWP) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>FWP</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Free writing prospectus (FWP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526210124/d244143dfwp.htm</link>
      <guid isPermaLink="false">0001193125-26-210124</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Free writing prospectus (FWP) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>FWP</category>
    </item>
    <item>
      <title><![CDATA[VRDN: 305B2]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526210120/d161096d305b2.htm</link>
      <guid isPermaLink="false">0001193125-26-210120</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a 305B2 (305B2) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>305B2</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526207208/d125234d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-207208</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Prospectus supplement (424B5) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526207203/d109155d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-207203</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Prospectus supplement (424B5) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000159075026000012/vrdn-20260331.htm</link>
      <guid isPermaLink="false">0001590750-26-000012</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Quarterly report (10-Q) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Free writing prospectus (FWP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526206789/d891067dfwp.htm</link>
      <guid isPermaLink="false">0001193125-26-206789</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Free writing prospectus (FWP) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>FWP</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526205099/d20977d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-205099</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526205010/d149508d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-205010</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526160354/d95955dars.pdf</link>
      <guid isPermaLink="false">0001193125-26-160354</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Annual report to shareholders (ARS) on 2026-04-17.]]></description>
      <pubDate>Fri, 17 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526160349/d904274ddefa14a.htm</link>
      <guid isPermaLink="false">0001193125-26-160349</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Proxy materials (DEFA14A) on 2026-04-17.]]></description>
      <pubDate>Fri, 17 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526160344/d904278ddef14a.htm</link>
      <guid isPermaLink="false">0001193125-26-160344</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Proxy statement (DEF 14A) on 2026-04-17.]]></description>
      <pubDate>Fri, 17 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526130433/d27955d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-130433</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2026-03-30.]]></description>
      <pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000010290926002586/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-002586</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526099023/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-099023</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (amended) (4/A) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526099014/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-099014</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (amended) (4/A) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526099008/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-099008</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (amended) (4/A) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526099007/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-099007</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (amended) (4/A) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000195917326001932/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001959173-26-001932</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider sale notice (144) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000195917326001929/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001959173-26-001929</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider sale notice (144) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000195917326001925/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001959173-26-001925</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider sale notice (144) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000195917326001921/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001959173-26-001921</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider sale notice (144) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526092074/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-092074</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526092071/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-092071</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526092068/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-092068</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (amended) (4/A) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526092065/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-092065</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (amended) (4/A) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526092040/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-092040</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526092036/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-092036</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526092028/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-092028</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000159075026000007/vrdn-20251231.htm</link>
      <guid isPermaLink="false">0001590750-26-000007</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Annual report (10-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526076844/d62671ds8.htm</link>
      <guid isPermaLink="false">0001193125-26-076844</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Employee stock plan (S-8) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526073391/d105707d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-073391</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000190788426000004/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001907884-26-000004</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000117266126000723/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001172661-26-000723</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-13.]]></description>
      <pubDate>Fri, 13 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312526001097/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-001097</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2026-01-02.]]></description>
      <pubDate>Fri, 02 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000195917325007945/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001959173-25-007945</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider sale notice (144) on 2025-12-31.]]></description>
      <pubDate>Wed, 31 Dec 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000183194225000032/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001831942-25-000032</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-11-14.]]></description>
      <pubDate>Fri, 14 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000159075025000020/vrdn-20250930.htm</link>
      <guid isPermaLink="false">0001590750-25-000020</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Quarterly report (10-Q) on 2025-11-05.]]></description>
      <pubDate>Wed, 05 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312525265711/d33707d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-265711</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2025-11-05.]]></description>
      <pubDate>Wed, 05 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[VRDN: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000110465925102608/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-25-102608</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2025-10-27.]]></description>
      <pubDate>Mon, 27 Oct 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000110465925102606/xslF345X05/tm2529526-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-25-102606</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Insider trade (4) on 2025-10-27.]]></description>
      <pubDate>Mon, 27 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[VRDN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1590750/000119312525247410/d27166d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-247410</guid>
      <description><![CDATA[Viridian Therapeutics, Inc.DE filed a Major company event (8-K) on 2025-10-23.]]></description>
      <pubDate>Thu, 23 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
  </channel>
</rss>